Data News > Top gainers in Biotechnology and Gene Therapy - VRTX, BIIB, DGX, BIO, GSK
VRTX is trading UP for the last 2 days, and it at trading at $455.05 with volume of 1,150,604 and a one day change of $12.00 (2.71%). Vertex Pharmaceuticals, Inc. has a 52-week low of 320.01 and a 52-week high of $457.66. The business's 50-day moving average price is $416.35 and its 200 day moving average price is $408.34. The firm has a market cap of $114 million, a P/E ratio of 25.09, and a beta of 0.39.
For more information on VRTX:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
BIIB is trading UP for the last 2 days, and it at trading at $225.00 with volume of 924,605 and a one day change of $4.93 (2.24%). Biogen Inc has a 52-week low of 189.44 and a 52-week high of $319.76. The business's 50-day moving average price is $213.27 and its 200 day moving average price is $228.93. The firm has a market cap of $32 million, a P/E ratio of 27.69, and a beta of -0.01.
NEW YORK, NY / ACCESSWIRE / May 31, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq: BIIB) Securities Class Action Lawsuit. If you invested in Biogen, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases/biogen-inc-investigation. NEW YORK, NY / ACCESSWIRE / May 31, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biogen-lawsuit-submission-form?prid=82394&wire=1 or contact Joseph E. Levi, Esq. NEW YORK, NY / ACCESSWIRE / May 31, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/biogen-lawsuit-submission-form?prid=82377&wire=1 or contact Joseph E. Levi, Esq. Biogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody for treating patients with amyotrophic lateral sclerosis (“ALS”) with superoxide dismutase 1 (“SOD1”) mutation. LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Company") (NASDAQ: BIIB ) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 3, 2022 and February 13, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before July 22, 2024.
For more information on BIIB:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
DGX is trading UP for the last 2 days, and it at trading at $141.97 with volume of 2,016,289 and a one day change of $2.64 (1.89%). Quest Diagnostics, Inc. has a 52-week low of 119.59 and a 52-week high of $145.62. The business's 50-day moving average price is $136.40 and its 200 day moving average price is $133.13. The firm has a market cap of $15 million, a P/E ratio of 18.63, and a beta of 0.87.
Circulating tumor DNA (ctDNA) testing for minimal residual disease (MRD) can reduce costs by up to 21% across health plan populations when half of eligible patients with stage II colorectal cancer are tested for treatment decisions SECAUCUS, N.J. and BALTIMORE , May 31, 2024 /PRNewswire/ -- A blood test could help reduce costs for health plans by reliably identifying patients who might be able to safely forgo chemotherapy after surgery for stage II colorectal cancer, according to a study published today in JAMA Health Forum, a member of the JAMA Network.
For more information on DGX:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
BIO is trading UP for the last 1 days, and it at trading at $286.86 with volume of 285,132 and a one day change of $4.85 (1.72%). Bio-Rad Laboratories Inc. has a 52-week low of 261.59 and a 52-week high of $431.79. The business's 50-day moving average price is $286.87 and its 200 day moving average price is $313.22. The firm has a market cap of $8 million, a P/E ratio of 0.00, and a beta of 0.94.
Identity, Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9am ET MINNEAPOLIS , May 31, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that Kim Kelderman, President and Chief Executive Officer will present at the following investor conferences: William Blair 44th Annual Growth Conference June 4, 2024 9:20 AM CDT Jefferies Global Healthcare Conference June 6, 2024 9:30 AM EDT Goldman Sachs 45th Annual Global Healthcare Conference June 11, 2024 9:20 AM EDT A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir-calendar. About Bio-Techne Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities.
For more information on BIO:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
GSK is trading UP for the last 1 days, and it at trading at $44.77 with volume of 3,372,663 and a one day change of $0.75 (1.70%). Glaxosmithkline plc has a 52-week low of 33.33 and a 52-week high of $45.93. The business's 50-day moving average price is $42.89 and its 200 day moving average price is $40.41. The firm has a market cap of $90 million, a P/E ratio of 16.57, and a beta of 0.27.
Glaxo (GSK) reported earnings 30 days ago. What's next for the stock?
For more information on GSK:
Historical Price Targets Hiistorical Analyst Recommendations Earning Price Impact Analysis Seasonality Analysis
Top gainers in Biotechnology and Gene Therapy - VRTX, BIIB, DGX, BIO, GSK
By KlickAnalytics Data Insights | May 31, 2024 04:40PM ET
Following are the Top 5 companies based on their one-day percentage change within the 'Biotechnology and Gene Therapy' theme.
Vertex Pharmaceuticals, Inc. (VRTX)
VRTX is trading UP for the last 2 days, and it at trading at $455.05 with volume of 1,150,604 and a one day change of $12.00 (2.71%). Vertex Pharmaceuticals, Inc. has a 52-week low of 320.01 and a 52-week high of $457.66. The business's 50-day moving average price is $416.35 and its 200 day moving average price is $408.34. The firm has a market cap of $114 million, a P/E ratio of 25.09, and a beta of 0.39.
For more information on VRTX:
Biogen Inc (BIIB)
BIIB is trading UP for the last 2 days, and it at trading at $225.00 with volume of 924,605 and a one day change of $4.93 (2.24%). Biogen Inc has a 52-week low of 189.44 and a 52-week high of $319.76. The business's 50-day moving average price is $213.27 and its 200 day moving average price is $228.93. The firm has a market cap of $32 million, a P/E ratio of 27.69, and a beta of -0.01.
Top news headlines for BIIB
For more information on BIIB:
Quest Diagnostics, Inc. (DGX)
DGX is trading UP for the last 2 days, and it at trading at $141.97 with volume of 2,016,289 and a one day change of $2.64 (1.89%). Quest Diagnostics, Inc. has a 52-week low of 119.59 and a 52-week high of $145.62. The business's 50-day moving average price is $136.40 and its 200 day moving average price is $133.13. The firm has a market cap of $15 million, a P/E ratio of 18.63, and a beta of 0.87.
Top news headlines for DGX
For more information on DGX:
Bio-Rad Laboratories Inc. (BIO)
BIO is trading UP for the last 1 days, and it at trading at $286.86 with volume of 285,132 and a one day change of $4.85 (1.72%). Bio-Rad Laboratories Inc. has a 52-week low of 261.59 and a 52-week high of $431.79. The business's 50-day moving average price is $286.87 and its 200 day moving average price is $313.22. The firm has a market cap of $8 million, a P/E ratio of 0.00, and a beta of 0.94.
Top news headlines for BIO
For more information on BIO:
Glaxosmithkline plc (GSK)
GSK is trading UP for the last 1 days, and it at trading at $44.77 with volume of 3,372,663 and a one day change of $0.75 (1.70%). Glaxosmithkline plc has a 52-week low of 33.33 and a 52-week high of $45.93. The business's 50-day moving average price is $42.89 and its 200 day moving average price is $40.41. The firm has a market cap of $90 million, a P/E ratio of 16.57, and a beta of 0.27.
Top news headlines for GSK
For more information on GSK:
This article was generated by KlickAnalytics data insight content engine.
To view full story, Upgrade to PRO plan!
Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.